In the United States, cannabidiol products generated sales of roughly five billion U.S. dollars in 2019, which was a truly significant increase, compared to the previous year. By 2023, CBD product sales are predicted to reach over 20 billion U.S. dollars in the United States. With estimated sales of 730 million U.S. dollars, the state of California was the country’s leading market for these products in 2019. By 2025, nutraceuticals are forecast to become the largest CBD category in terms of U.S. sales.
CBD products come in many different shapes and sizes, including tea, vape products, and soaps. Within the food segment, oils and spreads were the most common types of cannabidiol products in 2019. In American convenience stores, CBD vitamins were the leading segment in terms of sales, generating over 35 million U.S. dollars in the same year.
In 2019, CW Hemp was the top hemp-derived CBD brand among dispensary shoppers in the United States. About seven percent of cannabidiol users stated that this was their favorite brand. With approximately six and a half percent, the second most popular brand was Plus CBD Oil (CV Sciences). The leading CBD brand, sold in American c-stores, was Hemp Bombs mineral supplements in 2019. The brand generated about 20 million U.S. dollars in sales, while Hemp Bombs sleeping aid tablets, which ranked second, made roughly half that amount.
In 2019, an estimated eight percent of the adult population had used cannabidiol. That year, the most common reasons, for which adults in the United States stated to have tried CBD, included relaxation, stress relief and improved sleep. Usage is projected to increase with each upcoming year: by 2024, about a third of U.S. adults are expected to use these products.